PerkinElmer Reports Increased Revenues in Q4 | GenomeWeb

NEW YORK, Jan. 28 (GenomeWeb News) – PerkinElmer today reported revenues of $432.6 million for the fourth quarter ended Dec. 28, 2003, up from $410 million for the same period in 2002.

The increase, which included a 6 percent boost from foreign currency exchange rate fluctuations, was driven by revenue growth in all segments, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.